Abbott Laboratories (ABT)
NYSE: ABT
· Real-Time Price · USD
133.57
0.26 (0.20%)
At close: Sep 26, 2025, 3:59 PM
133.55
-0.01%
After-hours: Sep 26, 2025, 07:47 PM EDT
Abbott Laboratories Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 | Mar 31, 2012 | Sep 30, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostic Products Revenue | 5.9B | 2.05B | 2.52B | 2.41B | 2.19B | 2.21B | 2.77B | 2.45B | 2.08B | 2.69B | 3.08B | 3.9B | 4.32B | 5.29B | 4.47B | 3.91B | 3.25B | 4.01B | 4.34B | 2.64B | 1.99B | 1.83B | 2.06B | 1.91B | 1.91B | 1.84B | 1.96B | 1.82B | 1.87B | 1.84B | 1.91B | 1.28B | 1.27B | 1.16B | 1.26B | 1.21B | 1.23B | 1.12B | 1.22B | 1.16B | 1.18B | 1.09B | 1.24B | 1.18B | 1.19B | 1.12B | 1.2B | 1.13B | 1.14B | 1.09B | 1.13B | 1.04B | 1.08B | 1.04B | 1.02B |
| Diagnostic Products Revenue Growth | +187.24% | -18.49% | +4.48% | +9.89% | -0.86% | -20.22% | +13.31% | +17.97% | -22.77% | -12.61% | -21.13% | -9.76% | -18.24% | +18.23% | +14.29% | +20.48% | -19.11% | -7.62% | +64.58% | +32.40% | +9.20% | -11.27% | +7.81% | +0.21% | +3.48% | -6.12% | +7.51% | -2.62% | +1.96% | -3.62% | +49.02% | +0.47% | +9.93% | -7.80% | +3.54% | -1.06% | +9.66% | -8.36% | +5.54% | -1.78% | +7.69% | -11.50% | +4.66% | -0.76% | +6.45% | -6.68% | +6.40% | -0.88% | +4.32% | -3.72% | +8.45% | -3.34% | +3.45% | +1.66% | n/a |
| Established Pharmaceutical Products Revenue | 1.38B | 4.89B | 1.27B | 1.41B | 1.29B | 1.23B | 1.22B | 1.37B | 1.29B | 1.19B | 1.22B | 1.33B | 1.22B | 1.15B | 1.2B | 1.26B | 1.18B | 1.07B | 1.15B | 1.1B | 1.01B | 1.04B | 1.17B | 1.21B | 1.11B | 992M | 1.09B | 1.16B | 1.13B | 1.04B | 1.15B | 1.17B | 1.02B | 950M | 979M | 1.01B | 980M | 888M | 885M | 961M | 977M | 897M | -20M | 771M | 1.22B | 1.15B | 1.29B | 1.24B | 1.22B | 1.23B | -11.52B | 5.69B | 5.63B | 5.33B | 1.39B |
| Established Pharmaceutical Products Revenue Growth | -71.75% | +286.04% | -9.82% | +8.66% | +5.55% | +0.33% | -10.67% | +6.29% | +8.24% | -2.22% | -8.30% | +8.42% | +6.63% | -4.66% | -4.90% | +7.20% | +10.28% | -6.71% | +4.37% | +8.49% | -2.97% | -11.07% | -3.14% | +9.39% | +11.69% | -8.99% | -5.95% | +2.66% | +8.14% | -8.82% | -2.22% | +14.69% | +7.47% | -2.96% | -3.26% | +3.27% | +10.36% | +0.34% | -7.91% | -1.64% | +8.92% | -4585.00% | -102.59% | -36.60% | +5.65% | -10.64% | +4.29% | +1.40% | -1.22% | -110.70% | -302.53% | +1.14% | +5.57% | +283.66% | n/a |
| Medical Devices Revenue | 5.37B | 2.15B | 5.05B | 4.75B | 4.73B | 4.45B | 4.44B | 4.25B | 4.29B | 3.9B | 3.75B | 3.62B | 3.76B | 3.56B | 3.75B | 3.63B | 3.67B | 3.32B | 3.26B | 3.17B | 2.42B | 2.94B | 3.2B | 1.87B | 1.88B | 1.79B | 1.78B | 1.84B | 1.86B | 1.76B | 1.78B | 1.77B | 1.73B | 1.64B | 1.73B | 1.75B | 1.74B | 1.67B | 1.8B | 1.79B | 1.72B | 1.67B | 1.8B | 1.79B | 1.73B | 1.63B | 1.7B | 1.64B | 1.7B | 1.7B | 1.72B | 1.6B | 1.58B | 1.57B | 1.54B |
| Medical Devices Revenue Growth | +150.19% | -57.52% | +6.43% | +0.27% | +6.31% | +0.23% | +4.57% | -1.07% | +10.13% | +4.00% | +3.73% | -3.78% | +5.39% | -4.91% | +3.22% | -0.93% | +10.42% | +1.93% | +2.74% | +30.83% | -17.50% | -8.33% | +70.97% | -0.05% | +4.63% | +0.84% | -3.32% | -1.08% | +5.81% | -1.57% | +0.90% | +2.14% | +5.42% | -5.25% | -1.25% | +0.86% | +4.13% | -7.17% | +0.61% | +4.19% | +2.88% | -7.48% | +0.95% | +3.24% | +6.13% | -4.17% | +4.10% | -4.05% | +0.29% | -0.99% | +6.92% | +1.33% | +1.15% | +1.89% | n/a |
| Nutritional Products Revenue | 2.21B | 1.26B | 2.13B | 2.07B | 2.15B | 2.07B | 2.04B | 2.07B | 2.08B | 1.97B | 1.82B | 1.79B | 1.95B | 1.89B | 2.04B | 2.11B | 2.11B | 2.04B | 1.94B | 1.92B | 1.88B | 1.9B | 1.87B | 3.06B | 3.08B | 2.9B | 2.39B | 2.3B | 2.42B | 2.32B | 2.32B | 2.22B | 2.26B | 2.1B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Nutritional Products Revenue Growth | +75.56% | -40.82% | +3.05% | -3.91% | +3.97% | +1.47% | -1.69% | -0.14% | +5.54% | +8.26% | +1.23% | -8.09% | +3.12% | -7.25% | -3.13% | 0.00% | +3.54% | +5.17% | +0.62% | +2.18% | -1.10% | +1.93% | -39.05% | -0.33% | +6.22% | +21.13% | +3.78% | -4.87% | +4.22% | -0.04% | +4.50% | -1.59% | +7.47% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States Revenue | 4.28B | 4.17B | 6.63B | 4.2B | 3.93B | 3.85B | 6.29B | 3.82B | 3.76B | 3.93B | 5.87B | 4.09B | 4.89B | 6.96B | 6.61B | 4.37B | 6.64B | 6.62B | 6.5B | 5.52B | 4.69B | 4.87B | 5.35B | 5.24B | 5.13B | 4.78B | 7.97B | 4.95B | 5.07B | 4.71B |
| United States Revenue Growth | +2.59% | -37.16% | +57.85% | +6.81% | +2.29% | -38.87% | +64.84% | +1.57% | -4.33% | -33.11% | +43.43% | -16.31% | -29.69% | +5.22% | +51.40% | -34.24% | +0.36% | +1.78% | +17.70% | +17.78% | -3.70% | -9.04% | +2.14% | +2.20% | +7.28% | -40.01% | +61.04% | -2.29% | +7.42% | n/a |
| Non-Us Revenue | 6.87B | 6.19B | 4.34B | 6.43B | 6.44B | 6.12B | 3.95B | 6.33B | 6.22B | 5.82B | 4.22B | 6.32B | 6.37B | 4.94B | 4.86B | 6.56B | 3.58B | 3.84B | 4.2B | 3.33B | 2.64B | 2.86B | 2.96B | 2.83B | 2.85B | 2.75B | 2.75B | 2.71B | 2.7B | 2.67B |
| Non-Us Revenue Growth | +10.92% | +42.59% | -32.52% | -0.16% | +5.31% | +54.93% | -37.58% | +1.70% | +6.89% | +37.92% | -33.20% | -0.77% | +28.92% | +1.69% | -25.99% | +83.19% | -6.70% | -8.60% | +26.13% | +26.19% | -7.63% | -3.51% | +4.45% | -0.56% | +3.49% | -0.04% | +1.77% | +0.19% | +1.01% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.09B | 3.05B | 2.88B | 2.9B | 2.92B | 2.95B | 2.7B | 2.69B | 2.72B | 2.75B | 2.84B | 2.73B | 2.76B | 2.79B | 3B | 2.77B | 2.72B | 2.78B | 2.58B | 2.3B | 2.27B | 2.55B | 2.4B | 2.41B | 2.43B | 2.46B | 2.35B | 2.36B | 2.46B | 2.53B | 2.43B | 2.08B | 2.15B | 2.3B | 1.6B | 1.62B | 1.74B | 1.7B | 1.66B | 1.67B | 1.73B | 1.74B |
| Selling, General, and Administrative Revenue Growth | +1.31% | +6.01% | -0.52% | -0.92% | -1.08% | +9.25% | +0.33% | -1.06% | -0.98% | -3.10% | +4.15% | -1.12% | -1.08% | -7.22% | +8.60% | +1.58% | -2.16% | +8.08% | +12.15% | +0.92% | -10.71% | +6.03% | -0.46% | -0.78% | -1.14% | +4.90% | -0.64% | -3.91% | -2.77% | +4.08% | +16.73% | -3.26% | -6.48% | +43.33% | -0.87% | -6.85% | +2.30% | +2.60% | -0.66% | -3.53% | -0.58% | n/a |
| Research and Development Revenue | 732M | 703M | 728M | 713M | 697M | 683M | 690M | 661M | 710M | 654M | 691M | 780M | 684M | 697M | 758M | 672M | 654M | 654M | 698M | 580M | 564M | 576M | 575M | 594M | 577M | 670M | 561M | 573M | 573M | 581M | 618M | 493M | 520M | 541M | 338M | 336M | 348M | 379M | 369M | 378M | 345M | 313M |
| Research and Development Revenue Growth | +4.13% | -3.43% | +2.10% | +2.30% | +2.05% | -1.01% | +4.39% | -6.90% | +8.56% | -5.35% | -11.41% | +14.04% | -1.87% | -8.05% | +12.80% | +2.75% | 0.00% | -6.30% | +20.34% | +2.84% | -2.08% | +0.17% | -3.20% | +2.95% | -13.88% | +19.43% | -2.09% | 0.00% | -1.38% | -5.99% | +25.35% | -5.19% | -3.88% | +60.06% | +0.60% | -3.45% | -8.18% | +2.71% | -2.38% | +9.57% | +10.22% | n/a |